["{\n\"step_by_step_thinking\": \"The documents provided describe different aspects of primary hyperoxaluria, including its clinical features, biochemical treatments, and therapeutic strategies. One of the biochemical treatments mentioned is pyridoxine therapy, which reduces oxalate formation but does not normalize it. The document also discusses the unsuccessful treatment of primary hyperoxaluria with succinimide and renal transplantation performed in one patient. Additionally, there are references to various biochemical compounds that were investigated as possible inhibitors of oxalate production or urinary oxalate excretion. These findings suggest that primary hyperoxaluria is a complex condition requiring further research for effective treatment.\",\n\"answer_choice\": \"B: no\""]